EXCLUSIVE LICENCE AGREEMENT WITH RUTGERS UNIVERSITY
Lipotech has signed Exclusive Licence Agreement (Patents and IP Rights) with Rutgers University.
The License Agreement starts with co-development of Liposomal Cisplatin and Liposomal Carboplatin and their use in inhalation chemotherapies
EXCLUSIVE MANUFACTURING AGREEMENT WITH FORDOZ PHARMA FOR LIPOSOMAL ONCOLOGY DRUGS
Lipotech has signed Exclusive Manufacturing Agreement with ForDoz Pharma through know how it is bringing to the pilot manufacturing facility of ForDoz Pharma, with GMP certificates located in New Jersey
The manufacturing agreement will provide Liposomal Cisplatin and other Liposomal Oncology Drugs to be used for clinical trials
NASSOS ALEVIZOPOULOS (PhD) HAS JOINED OUR MANAGEMENT AS SCIENTIFIC BOARD MEMBER
The manufacturing Nassos Alevizopoulos (PhD) has joined our Management as Scientific Board Member where he will act as the leading personality coordinating scientific and regulatory affairs of Lipotech Inc. for the path that goes for Orphan Drug Designation from FDA or EMA